Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $2.59M in the quarter ending March 31, 2026, a decrease of -59.94%. This brings the company's revenue in the last twelve months to $36.49M, down -45.50% year-over-year. In the year 2025, Voyager Therapeutics had annual revenue of $40.37M, down -49.53%.

• Revenue (ttm): $36.49M
• Revenue Growth: -45.50%
• P/S Ratio: 6.87
• Revenue / Employee: $258,823
• Employees: 141
• Market Cap: 250.75M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	40.37M	-39.63M	-49.53%
Dec 31, 2024	80.00M	-170.01M	-68.00%
Dec 31, 2023	250.01M	209.10M	511.16%
Dec 31, 2022	40.91M	3.49M	9.33%
Dec 31, 2021	37.42M	-133.71M	-78.14%
Dec 31, 2020	171.13M	66.74M	63.93%
Dec 31, 2019	104.39M	96.77M	1,270.14%
Dec 31, 2018	7.62M	-2.52M	-24.82%
Dec 31, 2017	10.14M	-4.09M	-28.73%
Dec 31, 2016	14.22M	-3.11M	-17.96%
Dec 31, 2015	17.33M	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error